Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection-Reference-Cited by-同舟云学术

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection

Published:2014-12 Issue:6 Volume:102 Page:1633-1640.e5
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Arce Joan-Carles,Nyboe Andersen Anders,Fernández-Sánchez Manuel,Visnova Hana,Bosch Ernesto,García-Velasco Juan Antonio,Barri Pedro,de Sutter Petra,Klein Bjarke M.,Fauser Bart C.J.M.

Funder

Ferring Pharmaceuticals

Merck

Meso Scale Diagnostics

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference32 articles.

1. The science behind 25 years of ovarian stimulation for in vitro fertilization;Macklon;Endocr Rev,2006

2. Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis;Sterrenburg;Hum Reprod Update,2011

3. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology;Al-Inany;Cochrane Database Syst Rev,2011